Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lynch Syndrome Carriers' Uterine Cancer Health Assessment: Sampling and DNA-based Detection

NCT07194551 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT07194551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07194551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lynch Syndrome Carriers' Uterine Cancer Health Assessment: Sampling and DNA-based Detection
Lead sponsor
University of British Columbia
Phase
Not applicable
Overall status
Recruiting
Start date
August 29, 2025
Completion date
April 30, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, lynch syndrome